New York, NY (PRWEB) December 29, 2011
The Institute for Health Technology Transformation (iHT2) announced today that G. Cameron Deemer, President, DrFirst will serve as Conference Chair for the upcoming Electronic Prescribing of Controlled Substances (EPCS) Leadership Symposium taking place April 17-18, 2012 in Washington DC.
DrFirst has been in the forefront in the electronic transmission of controlled substance prescriptions developing the first-ever, fully certified solution that meets the prescription processing requirements set by Surescripts, the Drug Enforcement Administration requirements enforced through the Interim Final Rule (IFR) and identity proofing requirements set by the National Institute of Standards and Technology (NIST). DrFirst developed electronic prescription of controlled substances over two years working with the Massachusetts department of health and the Agency for Healthcare Research and Quality (AHRQ).
As conference chair G. Cameron Deemer will take a leadership role in shaping the content and curriculum of the EPCS Leadership Symposium. The EPCS Leadership Symposium will provide an opportunity for health care decision makers to gather, learn, and share the latest knowledge and advancements in the area of medication management, patient data security and the issues surrounding EPCS. The agenda will feature a preview of the latest clinical information technologies and strategies, panel discussions with industry experts, focus groups, and presentations on the latest e-prescribing issues and more.
“I am honored to be serving as conference chair of the EPCS Leadership Symposium,” says Deemer. “This symposium will cover a broad set of issues surrounding the electronic transmission of controlled substances including security, patient safety, law enforcement, protected patient information and innovative technology. This symposium has attracted highly respected experts who will provide attendees the opportunity to benefit from their experience and expertise in areas of safety, security, continuity of care and patient outcomes. Anyone who has a vested interest in the current and future state of strategy and policy relating to controlled substance e-prescribing will benefit by attending this symposium.”
The symposium aims to create a high level of awareness and education on electronic prescribing of controlled substances and healthcare security as well as encourage decision makers to reflect on the significance of EPCS and the implications it has for the healthcare industry as a whole.
Topics for the Symposium include: Pharmacy Adoption of EPCS, Chicken and Egg, Will Physicians or Pharmacies Go First?, Identity Proofing Methods and Issues, Penetration Prevention and Testing for EPCS, Token Selection, Implementation, and Management, EPCS and Fraud and Abuse, EPCS Impact for Hospitals and Communities, State and Federal EPCS Laws/Regulations, and more.
The two-day symposium is expected to draw 300 decision makers, HIT vendors, bloggers from the health care community, as well as policymakers from all levels of government. Participants should be committed to initiating and expanding EPCS within their organizations.
The early registration deadline for the conference is February 1, 2012. For more information on the program and details on attending, please contact:
Or visit the conference website at http://ihealthtran.com/epcs2012home.html.
About the Institute for Health Technology Transformation
The Institute for Health Technology Transformation is the leading organization committed to bringing together private and public sector leaders fostering the growth and effective use of technology across the healthcare industry. Through collaborative efforts the Institute provides programs that drive innovation, educate, and provide a critical understanding of how technology applications, solutions and devices can improve the quality, safety and efficiency of healthcare. http://www.ihealthtran.com